Publikationen
Swiontek K, Morisset M, Codreanu-Morel F, Fischer J, Mehlich J, Darsow U, Petitpain N, Biedermann T, Ollert M, Eberlein B, Hilger C. Drugs of porcine origin - a risk for patients with alpha-Gal syndrome? J Allergy Clin Immunol Pract 2018; epub ahead of print.
Mehlich J, Fischer J, Hilger C, Swiontek K, Morisset M, Codreanu-Morel F, Schiener M, Blank S, Ollert M, Darsow U, Biedermann T, Eberlein B. The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization. J Allergy Clin Immunol 2019; 143: 182-189
Russkamp D, Van Vaerenbergh M, Etzold S, Eberlein B, Darsow U, Schiener M, Se Smet L, Absmaier M, Biedermann T, Spillner E, Ollert M, Jakob T, Schmidt-Weber CB, de Graaf DC, Blank S. Characterization of the honeybee venom proteins C1q-like protein an PVF1 and their allergenic potential. Toxicon 2018; 150: 198-206
Schiener M, Hlger C, Eberlein B, Pascal M, Kuehn A, Revets D, Planchon S, Pietsch C, Serrano P, Moreno-Aguilar C, de la Roca F, Biedermann T, Darsow U, Schmidt-Weber CB, Ollert M, Blank S. The high molecular weight dipeptidyl peptidase IV Pol d 3 is a major allergen of Polistes dominula venom. Sci Rep 2018; 8: 1318
Eberlein B. Wigand S, Lewald H, Kochs E, Ring J, Biedermann T, Darsow U. Utility of basophil activation testing to assess perioperative anaphylactic reactions in real-world practice. Immun Inflamm Dis 2017; 5: 416-420
Blank S, Etzold S, Darsow U, Schiener M, Eberlein B, Russkamp D, Wolf S, Graessel A, Biedermann T, Ollert M, Schmidt-Weber CB. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honey bee venom allergy. Hum Vacc Immunother 2017; 13: 2482-2489
Fischer T, Eberlein B, Brockow K, Ollert M, Ring J, Darsow U. Rare ingestive food allergy to mushroom Boletus badius. Acta Derm Venerol 2017; 97: 1134-1135.
Franz-Oberdorf K, Eberlein B, Edelmann K, Bleicher P, Kurze E, Helm D, Olbricht K, Darsow U, Ring J, Schwab W. White-fruited strawberry genotypes are not per se hypoallergenic. Food Res Int. 2017 Oct; 100(Pt 1): 748-756
Schiener M, Eberlein B, Moreno-Aguilar C, Pietsch G, Serrano P, McIntyre M, Schwarze L, Russkamp D, Biedermann T, Spillner E, Darsow U, Ollert M, Schmidt-Weber CB, Blank S. Application of recombinant antigen 5 allergens from 7 allergy-relevant Hymenoptera species in diagnostics. Allergy 2017; 72: 98-108
Fischer J, Eberlein B, Hilger C, Eyer F, Eyerich S, Ollert M, Biedermann T. Alpha-gal is a possible target of IgE-mediated reactivity to antivenom. Allergy 2017; 72: 764-771
Hoffmann JH, Knol EF, Ferrer M, Mayorga L, Sabato V, Santos AF, Eberlein B, Nopp A, MacGlashan D. Pros and cons of clinical basophil testing (BAT). Curr Allergy Asthma Rep 2016; 16: 56
Eberlein B, Thomas P. Zelluläre Diagnostik in der Allergologie. In: Allergologie (Hrsg.: Biedermann T, Heppt W, Renz H, Röcken M); Springer-Verlag Berlin Heidelberg 2016; S 565-571
Eberlein B, Santos AF, Mayorga C, Nopp A, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF, Hoffmann HJ. Basophil activation testing in diagnosis and monitoring of allergic disease – an overview. Allergo J Int 2016; 25: 106
Franz-Oberdorf K, Eberlein B, Edelmann K, Hücherig S, Besbes F, Darsow U, Ring J, Schwab WG. Frau a 1.02 ist the most potent isoform of the Bet v 1-like allergen in strawberry fruit. J Agric Food Chem 2016;64: 3688-3696
Hilger C, Fischer J, Swiontek K, Hentges F, Lehners C, Eberlein B, Morisset M, Biedermann T, Ollert M. Two galactose-alpha-1,3-galactose carrying peptidases from pork kidney mediate anaphylactogenic reponses in delayed meat allergy. Allergy 2016; 71: 711-719
Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015; 70: 1393-1405
Eberlein B, Hann R, Eyerich S, Pennino D, Ring J, Schmidt-Weber CB, Buters J. Optimizing of the basophil activation test: Comparison of different basophil identifications markers. Cytometry B Clin Cytom 2015; 88: 183-189
Eberlein B, Krischan L, Darsow U, Ollert M, Ring J. Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants. J Allergy Clin Immunol 2012; 130: 155-161
Renz H, Biedermann T, Bufe A, Eberlein B, Jappe U, Ollert M, Petersen A, Kleine-Tebbe J, Raulf-Heimsoth M, Saloga J, Werfel T, Worm M. In-vitro-Allergiediagnostik. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI) unter Beteiligung des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) und der Deutschen Dermatologischen Gesellschaft (DDG). Allergo J 2010; 19: 110-12
Eberlein B, León Suárez I, Darsow U, Rueff F, Behrendt H, Ring J. A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy; 2010; 40: 411-418
Eberlein-König B, Varga R, Mempel M, Darsow U, Behrendt H, Ring J. Comparison of basophil activation tests using CD63 or CD203c expression in patients with insect venom allergy. Allergy 2006; 61: 1084-1085
Eberlein-König B, Schmidt-Leidescher C, Rakoski J, Behrendt H, Ring J. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J Investig Allergol Clin Immunol 2006; 16:5-10
Schober W, Belloni B, Lubitz S, Eberlein-König B, Bohn P, Saritas Y, Lintelmann J, Matuschek G, Behrendt H, Buters J. Organic extracts of urban aerosol (£PM2.5) enhance rBet v 1-induced upregulation of CD63 in basophils from birch pollen allergic individuals. Toxicol Sci 2006; 90: 377-384
Eberlein-König B, Rakoski J, Behrendt H, Ring J. Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy. J Investig Allergol Clin Immunol 2004; 14: 10-16